GVAG
TMO icon

Great Valley Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History

Great Valley Advisor Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Buy
8,223
+165
+2% +$79.2K 0.07% 257
2026
Q1 		$3.96M Buy
8,058
+684
+9% +$371K 0.07% 241
2025
Q4 		$4.27M Buy
7,374
+106
+1% +$59.9K 0.08% 214
2025
Q3 		$3.53M Buy
7,268
+1,452
+25% +$676K 0.07% 236
2025
Q2 		$2.36M Sell
5,816
-7,736
-57% -$3.23M 0.05% 289
2025
Q1 		$6.74M Buy
13,552
+1,443
+12% +$782K 0.15% 149
2024
Q4 		$6.3M Buy
12,109
+486
+4% +$267K 0.14% 146
2024
Q3 		$7.19M Buy
11,623
+739
+7% +$437K 0.18% 127
2024
Q2 		$6.02M Buy
10,884
+850
+8% +$487K 0.17% 134
2024
Q1 		$5.83M Buy
10,034
+338
+3% +$190K 0.18% 131
2023
Q4 		$5.15M Buy
9,696
+1,467
+18% +$710K 0.18% 134
2023
Q3 		$4.17M Buy
8,229
+624
+8% +$333K 0.17% 144
2023
Q2 		$3.97M Buy
7,605
+813
+12% +$439K 0.17% 149
2023
Q1 		$3.91M Sell
6,792
-271
-4% -$153K 0.18% 142
2022
Q4 		$3.89M Buy
7,063
+3,214
+84% +$1.7M 0.2% 128
2022
Q3 		$1.95M Sell
3,849
-26
-0.7% -$14.6K 0.11% 199
2022
Q2 		$2.11M Buy
3,875
+710
+22% +$391K 0.12% 191
2022
Q1 		$1.89M Buy
3,165
+526
+20% +$302K 0.11% 200
2021
Q4 		$1.75M Buy
2,639
+739
+39% +$461K 0.11% 200
2021
Q3 		$1.08M Sell
1,900
-49
-3% -$26.9K 0.07% 237
2021
Q2 		$980K Buy
1,949
+210
+12% +$99.1K 0.07% 243
2021
Q1 		$794K Buy
1,739
+291
+20% +$139K 0.08% 224
2020
Q4 		$675K Buy
1,448
+102
+8% +$47.8K 0.07% 237
2020
Q3 		$594K Sell
1,346
-188
-12% -$77.7K 0.07% 218
2020
Q2 		$557K Sell
1,534
-17
-1% -$5.7K 0.09% 218
2020
Q1 		$440K Sell
1,551
-225
-13% -$70.9K 0.12% 188
2019
Q4 		$577K Buy
1,776
+230
+15% +$69.7K 0.13% 189
2019
Q3 		$450K Buy
1,546
+109
+8% +$31.2K 0.11% 205
2019
Q2 		$422K Sell
1,437
-87
-6% -$24K 0.11% 203
2019
Q1 		$417K Buy
1,524
+85
+6% +$21.2K 0.13% 176
2018
Q4 		$322K Buy
+1,439
New +$338K 0.12% 154

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Great Valley Advisor Group's TMO Position: Q2 2026 in Review

Great Valley Advisor Group increased its Thermo Fisher Scientific (TMO) stake by 2% in Q2 2026, buying an estimated $79.2K and bringing the position to 8,223 shares worth $4.12M. The position accounts for 0.07% of the portfolio, ranked #257.

Great Valley Advisor Group first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.19M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Great Valley Advisor Group held 8,223 shares of Thermo Fisher Scientific worth $4.12M as of Q2 2026.
  • Great Valley Advisor Group bought 165 Thermo Fisher Scientific shares in Q2 2026, an estimated $79.2K.
  • Thermo Fisher Scientific made up 0.07% of Great Valley Advisor Group's portfolio in Q2 2026, its #257 holding.
  • Great Valley Advisor Group first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • Great Valley Advisor Group's Thermo Fisher Scientific position peaked at $7.19M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.